Eris Lifesciences Limited (ERIS) — Cash Flow Quality Index
Eris Lifesciences Limited (ERIS) has a Cash Flow Quality Index of 1.99x as of September 2025. Operating cash flow of Rs2.39 Billion exceeds net income of Rs1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore ERIS cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eris Lifesciences Limited Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Eris Lifesciences Limited across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ERIS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Eris Lifesciences Limited (2012–2025)
Year-by-year earnings quality comparison for Eris Lifesciences Limited. For live market cap and the full company financial profile, see Eris Lifesciences Limited market cap and net worth.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.03x | Rs10.65 Billion | Rs3.52 Billion | ▲ +144.1% |
| 2024 | 1.24x | Rs4.86 Billion | Rs3.92 Billion | ▲ +72.0% |
| 2023 | 0.72x | Rs2.92 Billion | Rs4.05 Billion | ▼ -15.7% |
| 2022 | 0.86x | Rs3.78 Billion | Rs4.42 Billion | ▼ -10.1% |
| 2021 | 0.95x | Rs3.75 Billion | Rs3.94 Billion | ▲ +16.3% |
| 2020 | 0.82x | Rs2.71 Billion | Rs3.31 Billion | ▲ +16.4% |
| 2019 | 0.70x | Rs2.23 Billion | Rs3.17 Billion | ▼ -6.5% |
| 2018 | 0.75x | Rs2.35 Billion | Rs3.12 Billion | ▼ -0.8% |
| 2017 | 0.76x | Rs2.00 Billion | Rs2.64 Billion | ▼ -11.0% |
| 2016 | 0.85x | Rs1.31 Billion | Rs1.54 Billion | ▲ +3.4% |
| 2015 | 0.82x | Rs900.57 Million | Rs1.09 Billion | ▼ -9.7% |
| 2014 | 0.91x | Rs896.24 Million | Rs983.25 Million | ▲ +99.3% |
| 2013 | 0.46x | Rs380.15 Million | Rs831.39 Million | ▼ -44.2% |
| 2012 | 0.82x | Rs302.99 Million | Rs369.43 Million | — |